Related Experiment Video
Updated: Sep 12, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Predicting Infection Risk in Rheumatoid Arthritis Patients Treated with Biological and Targeted Synthetic
Kuan Peng1,2, Deliang Yang1,2, Jiaqi Wang2
1Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Abstract:
Patients with rheumatoid arthritis (RA) on biologic or targeted synthetic DMARDs (b/ts DMARDs) face increased serious infection risk. This study developed and validated a machine learning model to predict one-year risk using data from Hong Kong's CDARS and the U.S. All of Us database. Among 3,159 CDARS and 1,845 All of Us patients, AUROCs were 0.840 and 0.729. Key predictors included prior infections, diabetes, DMARD type, and inflammatory markers. Rituximab posed the highest risk. The model supports personalized RA treatment and infection prevention.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Steps in Outbreak Investigation
The JAK-STAT Signaling Pathway